Danaher EBITDA 2010-2022 | DHR

Danaher annual and quarterly EBITDA history from 2010 to 2022. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Danaher EBITDA for the quarter ending March 31, 2022 was $2.737B, a 8.27% increase year-over-year.
  • Danaher EBITDA for the twelve months ending March 31, 2022 was $9.901B, a 23.82% increase year-over-year.
  • Danaher 2021 annual EBITDA was $9.692B, a 49.96% increase from 2020.
  • Danaher 2020 annual EBITDA was $6.463B, a 44.98% increase from 2019.
  • Danaher 2019 annual EBITDA was $4.458B, a 5.32% increase from 2018.
Danaher Annual EBITDA
(Millions of US $)
2021 $9,692
2020 $6,463
2019 $4,458
2018 $4,233
2017 $3,689
2016 $3,863
2015 $3,043
2014 $2,763
2013 $3,971
2012 $4,005
2011 $3,252
2010 $2,438
2009 $1,771
Danaher Quarterly EBITDA
(Millions of US $)
2022-03-31 $2,737
2021-12-31 $2,754
2021-09-30 $1,880
2021-06-30 $2,530
2021-03-31 $2,528
2020-12-31 $2,149
2020-09-30 $1,800
2020-06-30 $1,519
2020-03-31 $995
2019-12-31 $1,261
2019-09-30 $1,072
2019-06-30 $1,110
2019-03-31 $1,016
2018-12-31 $815
2018-09-30 $1,152
2018-06-30 $1,202
2018-03-31 $1,064
2017-12-31 $716
2017-09-30 $1,071
2017-06-30 $980
2017-03-31 $923
2016-12-31 $1,019
2016-09-30 $976
2016-06-30 $988
2016-03-31 $881
2015-12-31 $265
2015-09-30 $616
2015-06-30 $1,171
2015-03-31 $991
2014-12-31 $941
2014-09-30 $1,071
2014-06-30 $1,125
2014-03-31 $1,014
2013-12-31 $1,077
2013-09-30 $1,038
2013-06-30 $1,063
2013-03-31 $948
2012-12-31 $1,083
2012-09-30 $966
2012-06-30 $1,019
2012-03-31 $937
2011-12-31 $983
2011-09-30 $851
2011-06-30 $729
2011-03-31 $689
2010-12-31 $659
2010-09-30 $649
2010-06-30 $615
2010-03-31 $515
2009-12-31 $370
2009-09-30 $550
2009-06-30 $430
2009-03-31 $421
Sector Industry Market Cap Revenue
Multi-Sector Conglomerates Diversified Operations $187.622B $29.453B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
3M (MMM) United States $73.118B 12.85
General Electric (GE) United States $69.936B 29.83
Carlisle (CSL) United States $12.470B 19.56
ITT (ITT) United States $5.636B 17.05
Federal Signal (FSS) United States $2.150B 20.62
Griffon (GFF) United States $1.639B 11.40
Lsb Industries (LXU) United States $1.141B 7.99
Steel Partners Holdings LP (SPLP) United States $0.888B 12.65
National Presto Industries (NPK) United States $0.466B 23.96
Macquarie Infrastructure Holdi (MIC) United States $0.357B 0.00
INNOVATE (VATE) United States $0.129B 0.00